Disclosure Of Interests In Other Entities [Text Block]

Ascelia Pharma - Filing #701899

Concept	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2019-12-31
Disclosure of interests in other entities [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Profit (loss), attributable to non-controlling interests	—	—	—	—	—	—	- SEK	—	—	—	- SEK	—	—	—	—	—	—
Current assets	—	274 611 SEK	—	—	—	—	—	—	—	196 324 SEK	—	—	—	—	—	—	—
Non-current assets	—	58 882 SEK	—	—	—	—	—	—	—	59 050 SEK	—	—	—	—	—	—	—
Current liabilities	—	25 106 SEK	—	—	—	—	—	—	—	18 362 SEK	—	—	—	—	—	—	—
Non-current liabilities	—	553,000 SEK	—	—	—	—	—	—	—	956,000 SEK	—	—	—	—	—	—	—
Revenue	—	—	—	—	—	—	- SEK	—	—	—	- SEK	—	—	—	—	—	—
Profit (loss)	- SEK	—	- SEK	- SEK	125 903 SEK	- SEK	125 903 SEK	125 903 SEK	98 697 SEK	—	98 697 SEK	- SEK	- SEK	- SEK	98 697 SEK	- SEK	—
Comprehensive income	– SEK	—	– SEK	135,000 SEK	125 768 SEK	– SEK	125 768 SEK	125 903 SEK	98 697 SEK	—	98 702 SEK	– SEK	5,000 SEK	– SEK	98 702 SEK	– SEK	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income	—	—	—	—	—	—	135,000 SEK	—	—	—	5,000 SEK	—	—	—	—	—	—
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	—	261 599 SEK	—	—	—	—	—	—	—	184 686 SEK	—	—	—	—	—	—	108 516 SEK
Tax expense (income)	—	—	—	—	—	—	3 620 SEK	—	—	—	1 050 SEK	—	—	—	—	—	—